0 Σχόλια
0 Μοιράστηκε
409 Views
0 Προεπισκόπηση
Αναζήτηση
Ανακάλυψε νέους ανθρώπους, δημιούργησε νέες συνδέσεις και κάνε καινούργιους φίλους
-
Παρακαλούμε συνδέσου στην Κοινότητά μας για να δηλώσεις τι σου αρέσει, να σχολιάσεις και να μοιραστείς με τους φίλους σου!
-
Infectious Disease Rapid Diagnostic Testing Market Outlook and AnalysisThe infectious disease rapid diagnostic testing market is growing due to the increasing need for quick and accurate disease detection, rising infectious disease cases, and advancements in diagnostic technologies. The demand for rapid testing solutions is increasing across hospitals, laboratories, and healthcare facilities to support timely diagnosis and treatment decisions. The Infectious...0 Σχόλια 0 Μοιράστηκε 321 Views 0 Προεπισκόπηση
-
Point-of-Care Glucose Testing Market to Reach US$ 5.8 Billion by 2032 as Demand for Rapid Diabetes Monitoring AcceleratesThe global healthcare industry is witnessing a significant transformation driven by the growing prevalence of diabetes and the increasing need for fast, accurate, and convenient diagnostic solutions. Among these innovations, point-of-care (POC) glucose testing has become an indispensable tool for healthcare professionals and patients alike. These devices enable immediate blood glucose...0 Σχόλια 0 Μοιράστηκε 305 Views 0 Προεπισκόπηση
-
Rapid Microbiology Testing Market Booming Due to Faster Diagnostic Requirements"According to the latest report published by Data Bridge Market Research, the Rapid Microbiology Testing Market The global rapid microbiology testing market size was valued at USD 5.40 billion in 2024 and is expected to reach USD 11.09 billion by 2032, at a CAGR of 9.40% during the forecast period This Rapid Microbiology Testing Market research report...0 Σχόλια 0 Μοιράστηκε 482 Views 0 Προεπισκόπηση
-
Rapid Microbiology Testing Market Growth Accelerates with Faster Diagnostic Technologies"According to the latest report published by Data Bridge Market Research, the Rapid Microbiology Testing Market The global rapid microbiology testing market size was valued at USD 5.40 billion in 2024 and is expected to reach USD 11.09 billion by 2032, at a CAGR of 9.40% during the forecast period Market definition mentioned in this Rapid Microbiology...0 Σχόλια 0 Μοιράστηκε 346 Views 0 Προεπισκόπηση
-
Rapid Microbiology Testing Market Size & Forecast 2026–2033" According to the latest report published by Data Bridge Market Research, the Rapid Microbiology Testing Market The global rapid microbiology testing market size was valued at USD 5.40 billion in 2024 and is expected to reach USD 11.09 billion by 2032, at a CAGR of 9.40% during the forecast period With the use of integrated approaches and latest...0 Σχόλια 0 Μοιράστηκε 165 Views 0 Προεπισκόπηση
-
Rising Demand for Rapid Testing Accelerates Paper Diagnostics Market ExpansionThe North America Paper Diagnostics market is experiencing steady growth due to the increasing demand for rapid, cost-effective, and accessible diagnostic solutions across healthcare settings. The region continues to invest in advanced point-of-care testing technologies that support early disease detection and efficient patient management. Growing awareness regarding preventive healthcare,...0 Σχόλια 0 Μοιράστηκε 380 Views 0 Προεπισκόπηση
-
Adenosine Triphosphate (ATP) Swab Test Market Dynamics, Challenges and OpportunitiesThe global Adenosine Triphosphate (ATP) swab test market is witnessing significant growth due to rising awareness regarding hygiene monitoring, increasing concerns about contamination control, and growing demand for rapid cleanliness verification solutions across healthcare, food processing, and pharmaceutical industries. ATP swab testing is widely used to detect biological residues and...0 Σχόλια 0 Μοιράστηκε 1χλμ. Views 0 Προεπισκόπηση
-
Biomonitoring and Bioburden Testing Market to Reach USD 6.2 Billion by 2031 | CAGR 7.2%According to a newly published market research report by 24LifeSciences, global biomonitoring and bioburden testing market was valued at USD 3.5 billion in 2024 and is projected to reach USD 6.2 billion by 2031, growing at a compound annual growth rate (CAGR) of 7.2% during the forecast period 2025-2031. Biomonitoring involves the measurement of toxic substances in biological specimens, while...0 Σχόλια 0 Μοιράστηκε 4χλμ. Views 0 Προεπισκόπηση
-
Biomonitoring and Bioburden Testing Market to Reach USD 6.2 Billion by 2031 | CAGR 7.2%According to a newly published market research report by 24LifeSciences, global biomonitoring and bioburden testing market was valued at USD 3.5 billion in 2024 and is projected to reach USD 6.2 billion by 2031, growing at a compound annual growth rate (CAGR) of 7.2% during the forecast period 2025-2031. Biomonitoring involves the measurement of toxic substances in biological specimens, while...0 Σχόλια 0 Μοιράστηκε 4χλμ. Views 0 Προεπισκόπηση
-
Global Point-of-Care Molecular Diagnostics Market Growth, Innovations, and Forecast to 2034The Global Point-of-Care Molecular Diagnostics Market is rapidly evolving as healthcare systems increasingly prioritize faster, accurate, and decentralized diagnostic solutions. Point-of-care (POC) molecular diagnostics enable testing near the patient, delivering rapid results that support timely clinical decision-making. These technologies are widely used in detecting infectious diseases,...0 Σχόλια 0 Μοιράστηκε 2χλμ. Views 0 Προεπισκόπηση
-
Hospital-Acquired Disease Testing Market Size US$ 2,032 Million by 2031Hospital-Acquired Disease Testing plays a vital role in strengthening infection prevention strategies within healthcare facilities. It enables the timely identification of pathogens responsible for healthcare-associated infections, helping clinicians initiate targeted treatment and containment measures. By supporting continuous surveillance and quality control, these testing solutions...0 Σχόλια 0 Μοιράστηκε 3χλμ. Views 0 Προεπισκόπηση
-
Hospital-Acquired Disease Testing Market to Reach USD 724 Million by 2031 | CAGR 5.6%According to a newly published market research report by 24LifeSciences, global hospital-acquired disease testing market was valued at USD 498 million in 2024 and is projected to reach USD 724 million by 2031, growing at a compound annual growth rate (CAGR) of 5.6% during the forecast period 2026–2034. Hospital-acquired infections (HAIs), clinically significant as nosocomial...0 Σχόλια 0 Μοιράστηκε 3χλμ. Views 0 Προεπισκόπηση
-
Immunoassay Market Insights: Investment Opportunities Through 2031Immunoassay Market share growth is reinforced by continuous improvements in assay sensitivity and specificity. Enhanced performance ensures reliable clinical outcomes. This technological progress strengthens trust among healthcare professionals. The immunoassay market share is projected to experience sustained growth through 2031, supported by technological innovation, expanding disease burden,...0 Σχόλια 0 Μοιράστηκε 5χλμ. Views 0 Προεπισκόπηση1
-
Immunodiagnostics Market to Reach USD 17.68 Billion by 2031 | CAGR 6.3%According to a newly published market research report by 24LifeSciences, global immunodiagnostics market was valued at USD 11,660 million in 2024 and is projected to reach USD 17,680 million by 2031, growing at a compound annual growth rate (CAGR) of 6.3% during the forecast period 20252031. Immunodiagnostics involves advanced testing...0 Σχόλια 0 Μοιράστηκε 2χλμ. Views 0 Προεπισκόπηση
-
Key Innovations Fueling Growth in the Cardiac POC Testing Devices IndustryRising geriatric population is another key driver fueling demand.Older adults are more prone to heart-related conditions requiring frequent monitoring.This demographic trend is expected to sustain long-term market growth. The Cardiac POC Testing Devices Market report by The Insight Partners provides a comprehensive evaluation of the current industry landscape and its projected growth trajectory...0 Σχόλια 0 Μοιράστηκε 6χλμ. Views 0 Προεπισκόπηση
-
Nucleic Acid Mobile Collection Cabin Market to Reach USD 280 Million by 2032 | CAGR 11.2%According to a newly published market research report by 24LifeSciences, the global nucleic acid mobile collection cabin market was valued at USD 120 million in 2024 and is projected to reach USD 280 million by 2032, growing at a compound annual growth rate (CAGR) of 11.2% during the forecast period 20252032. Nucleic Acid Mobile Collection Cabins are portable, biosafety-compliant modular units...0 Σχόλια 0 Μοιράστηκε 3χλμ. Views 0 Προεπισκόπηση
-
Point-of-Care Testing Devices Market Analysis 2026-2034The Point-of-Care Testing Devices industry is anticipated to record steady growth from 2026 to 2034. Starting from the 2025 baseline, the market is expected to progress through sustained expansion during the forecast period. This trend reflects a favorable market outlook, driven by evolving healthcare requirements, technological innovations, and rising demand for quick and accurate diagnostic...0 Σχόλια 0 Μοιράστηκε 2χλμ. Views 0 Προεπισκόπηση
Αναζήτηση αποτελεσμάτων